Envestnet Asset Management Inc. decreased its holdings in shares of Steris PLC (NYSE:STE) by 2.4% in the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 146,104 shares of the medical equipment provider’s stock after selling 3,629 shares during the quarter. Envestnet Asset Management Inc. owned about 0.17% of Steris worth $12,916,000 as of its most recent SEC filing.
Other institutional investors have also added to or reduced their stakes in the company. The Manufacturers Life Insurance Company grew its holdings in shares of Steris by 1.6% during the second quarter. The Manufacturers Life Insurance Company now owns 122,520 shares of the medical equipment provider’s stock worth $9,986,000 after buying an additional 1,963 shares in the last quarter. State of Wisconsin Investment Board purchased a new stake in shares of Steris during the second quarter worth $1,360,000. Prudential Financial Inc. grew its holdings in shares of Steris by 14.4% during the third quarter. Prudential Financial Inc. now owns 192,686 shares of the medical equipment provider’s stock worth $17,034,000 after buying an additional 24,220 shares in the last quarter. GWM Advisors LLC grew its holdings in shares of Steris by 59.8% during the second quarter. GWM Advisors LLC now owns 6,741 shares of the medical equipment provider’s stock worth $553,000 after buying an additional 2,522 shares in the last quarter. Finally, Shelton Capital Management purchased a new stake in shares of Steris during the second quarter worth $464,000. 89.45% of the stock is owned by institutional investors and hedge funds.
Shares of Steris PLC (NYSE STE) traded down $0.08 on Thursday, hitting $89.00. 333,000 shares of the company were exchanged, compared to its average volume of 459,236. The company has a debt-to-equity ratio of 0.48, a current ratio of 2.80 and a quick ratio of 2.18. Steris PLC has a 12-month low of $65.26 and a 12-month high of $93.39. The stock has a market capitalization of $7,576.46, a price-to-earnings ratio of 22.96 and a beta of 1.27.
The business also recently announced a quarterly dividend, which will be paid on Wednesday, December 20th. Shareholders of record on Wednesday, November 22nd will be paid a dividend of $0.31 per share. This represents a $1.24 annualized dividend and a yield of 1.39%. The ex-dividend date of this dividend is Tuesday, November 21st. Steris’s dividend payout ratio (DPR) is presently 73.81%.
A number of equities research analysts recently issued reports on STE shares. Zacks Investment Research lowered shares of Steris from a “buy” rating to a “sell” rating in a report on Monday, November 6th. KeyCorp reissued a “buy” rating and issued a $91.00 price objective on shares of Steris in a report on Tuesday, October 17th. Raymond James Financial upped their price objective on shares of Steris from $90.00 to $95.00 and gave the company an “outperform” rating in a report on Wednesday, August 9th. Finally, TD Securities upped their price objective on shares of Steris from C$14.00 to C$16.00 and gave the company a “buy” rating in a report on Thursday, November 9th. One equities research analyst has rated the stock with a sell rating, one has given a hold rating and four have given a buy rating to the stock. The stock presently has an average rating of “Buy” and a consensus target price of $79.50.
In other Steris news, CEO Walter M. Rosebrough, Jr. sold 10,000 shares of the stock in a transaction dated Wednesday, October 4th. The shares were sold at an average price of $90.50, for a total transaction of $905,000.00. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Richard Martin Steeves sold 156,072 shares of the stock in a transaction dated Friday, September 8th. The stock was sold at an average price of $87.13, for a total transaction of $13,598,553.36. Following the transaction, the director now directly owns 9,362 shares of the company’s stock, valued at approximately $815,711.06. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 192,722 shares of company stock valued at $16,913,753. 2.55% of the stock is currently owned by insiders.
ILLEGAL ACTIVITY NOTICE: “Envestnet Asset Management Inc. Reduces Stake in Steris PLC (STE)” was published by Chaffey Breeze and is the sole property of of Chaffey Breeze. If you are viewing this report on another site, it was stolen and reposted in violation of US and international trademark and copyright legislation. The legal version of this report can be viewed at https://www.chaffeybreeze.com/2017/12/07/envestnet-asset-management-inc-reduces-stake-in-steris-plc-ste.html.
Steris Company Profile
STERIS plc provides infection prevention and other procedural products and services. The Company operates through four segments: Healthcare Products, which offers infection prevention and procedural solutions for healthcare providers, including capital equipment and related maintenance, and installation services, as well as consumables; Healthcare Specialty Services, which provides a range of specialty services for healthcare providers, including hospital sterilization services, instrument and scope repairs, and linen management; Life Sciences, which offers capital equipment and consumable products, and equipment maintenance and specialty services for pharmaceutical manufacturers and research facilities, and Applied Sterilization Technologies, which offers contract sterilization and laboratory services for medical device and pharmaceutical customers and others.
Receive News & Ratings for Steris PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Steris PLC and related companies with MarketBeat.com's FREE daily email newsletter.